GE Healthcare announces new mammography system

Freeman Staff

Sept. 6, 2017

WAUKESHA — A new technology unveiled by GE Healthcare on Tuesday allows women to be in control of their mammograms.

The Senographe Pristina Dueta is a remote control that allows women to manage their own compression during the exam performed on the company’s new mammography system, Senographe Pristina. The new control just received clearance from the FDA.

“Mammograms can be uncomfortable or even painful,” said Agnes Berzsenyi, president and CEO of GE Healthcare Women’s Health, in a statement. “Engineered by a team of women for women, GE Healthcare has transformed mammography with the creation of patient-assisted compression to decrease pain associated with the exam, improve patient experience and increase outcomes for breast cancer screening which we know saves lives.”

Traditionally, a technologist who performs the mammogram exam compresses the patient’s breast, sometimes resulting in discomfort. The Senographe Pristina Dueta will allow women to control the application of compression to minimize the perceived pain and discomfort often associated with a mammogram, according to the announcement. After the breast is properly positioned by the technologist, the patient can use a handheld wireless remote control to command Senographe Pristina to adjust the compression paddle based on the patient’s comfort level.

“This is a new age in breast imaging,” said Dr. Kathy Schilling, medical director of the Boca Raton Regional Hospital’s Christine E. Lynn Women’s Health & Wellness Center and the radiologist who conducted a clinical review of the new tool. “Patients who used the remote control said the exam was more comfortable and they were visibly more relaxed. Any breast radiologist knows that when patients are relaxed, we are able to get better images and better images lead to a more confident diagnosis. My hope is that increasing comfort during the exam and giving patients the option of working with the technologist to set their own compression will increase compliance, enable early detection and improve outcomes.”